William Blair Maintains Buy Rating for Option Care Health (OPCH)
PorAinvest
miércoles, 20 de agosto de 2025, 1:43 pm ET1 min de lectura
OPCH--
Analysts have mixed signals for the stock. While the short-term Moving Average holds a buy signal, the long-term average gives a general sell signal. The stock is expected to fall -13.56% during the next three months, with a 90% probability of holding a price between $23.68 and $25.79. However, if the stock price manages to stay at current levels or higher, the prediction target will change positively.
Citigroup Inc. has lowered its position in Option Care Health by 3.9% in the first quarter, selling 21,992 shares. Other institutional investors, such as Public Employees Retirement System of Ohio and Johnson Financial Group Inc., have also bought and sold shares of the company. Several brokerages have issued reports on OPCH, with Citigroup, JMP Securities, Barrington Research, and UBS Group maintaining or upgrading their ratings to "outperform" or "buy."
Matt Larew of William Blair maintains a Buy rating for Option Care Health, despite the company's shares opening at $26.69. Larew has a 41.27% success rate and an average return of -6.1%. TipRanks suggests a Strong Buy consensus rating with a $38.20 average price target. The stock has a one-year high of $35.53 and a one-year low of $21.39, with an average volume of 1.53M.
Option Care Health's stock is expected to open at $28.51 on August 20, 2025, with a possible trading interval of +/-$0.762 (+/-2.71%) up or down from the last closing price. The stock has medium daily movements and medium risk, with a recommended stop-loss at $27.06 (-5.24%).
Option Care Health should be considered a Hold candidate at the current level, awaiting further development. The stock has been upgraded from a Sell candidate to a Hold candidate.
References:
[1] https://stockinvest.us/stock/OPCH
[2] https://www.marketbeat.com/instant-alerts/filing-citigroup-inc-sells-21992-shares-of-option-care-health-inc-nasdaqopch-2025-08-14/
William Blair analyst Matt Larew maintains a Buy rating for Option Care Health, despite the company's shares opening at $26.69. Larew has a 41.27% success rate and an average return of -6.1%. TipRanks suggests a Strong Buy consensus rating with a $38.20 average price target. Option Care Health has a one-year high of $35.53 and a one-year low of $21.39, with an average volume of 1.53M.
Option Care Health Inc. (OPCH), a provider of home and alternate site infusion services in the United States, has seen its stock upgraded to a Hold/Accumulate rating by analysts. The stock price gained 1.28% on August 19, 2025, rising from $28.19 to $28.55. The stock has fallen in 7 of the last 10 days but is still up by 1.6% over the past two weeks.Analysts have mixed signals for the stock. While the short-term Moving Average holds a buy signal, the long-term average gives a general sell signal. The stock is expected to fall -13.56% during the next three months, with a 90% probability of holding a price between $23.68 and $25.79. However, if the stock price manages to stay at current levels or higher, the prediction target will change positively.
Citigroup Inc. has lowered its position in Option Care Health by 3.9% in the first quarter, selling 21,992 shares. Other institutional investors, such as Public Employees Retirement System of Ohio and Johnson Financial Group Inc., have also bought and sold shares of the company. Several brokerages have issued reports on OPCH, with Citigroup, JMP Securities, Barrington Research, and UBS Group maintaining or upgrading their ratings to "outperform" or "buy."
Matt Larew of William Blair maintains a Buy rating for Option Care Health, despite the company's shares opening at $26.69. Larew has a 41.27% success rate and an average return of -6.1%. TipRanks suggests a Strong Buy consensus rating with a $38.20 average price target. The stock has a one-year high of $35.53 and a one-year low of $21.39, with an average volume of 1.53M.
Option Care Health's stock is expected to open at $28.51 on August 20, 2025, with a possible trading interval of +/-$0.762 (+/-2.71%) up or down from the last closing price. The stock has medium daily movements and medium risk, with a recommended stop-loss at $27.06 (-5.24%).
Option Care Health should be considered a Hold candidate at the current level, awaiting further development. The stock has been upgraded from a Sell candidate to a Hold candidate.
References:
[1] https://stockinvest.us/stock/OPCH
[2] https://www.marketbeat.com/instant-alerts/filing-citigroup-inc-sells-21992-shares-of-option-care-health-inc-nasdaqopch-2025-08-14/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios